Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer

NCT00160875 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: Irinotecan hydrochloride trihydrate
DRUG: Cisplatin

Sponsor

University Health Network, Toronto

Collaborators

[object Object]